Covance
Contact Us   |  Client Login  

  • PRODUCTS & SERVICES
    • Antibody Products
      • Antibody Products Store
      • Neuroscience
      • Epitope Tags
      • Structural Proteins & Cell Components
      • Signal Transduction
      • Immunopathology
      • Detection Chemistries & Ancillaries
      • Custom Immunology Services
    • Clinical Services
      • Bioanalytical
      • Central Laboratory
      • Clinical Development (Phase I-III)
    • Discovery & Translational Services
      • Antibody Products
      • Biomarker Center of Excellence
      • BioPathways
      • Computational Biology
      • Discovery
      • Genomics Laboratory
      • Immunology
      • Vaccines & Infectious Disease
    • Nonclinical Services
      • Antibody Products
      • Bioanalytical Services
      • Discovery
      • Drug Metabolism & Pharmacokinetics
      • Immunology
      • Radiosynthesis
      • Research Models
      • Safety Pharmacology
      • Toxicology
      • Vaccines & Infectious Disease
    • Biopharmaceutical CMC Solutions
    • Biorepository Services
    • Environmental Sciences
    • Genomics Laboratory
    • Integration in Drug Development
    • Market Access
    • Nutritional Chemistry & Food Safety
    • Secure Data Access
    • Strategic Partnering

  • CAREERS
    • Search Jobs
    • College / University
    • Featured Jobs
    • Diversity
    • Benefits
    • 现在就加入科文斯

  • STUDY PARTICIPANTS

  • INVESTORS
    • Investor Information
      • Investor Home
      • Stock Information
      • Board of Directors
      • Corporate Governance Guidelines
      • Analyst Coverage
      • Investor FAQ
      • Presentations & Webcasts
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Press Releases
    • Calendar of Events
    • Request Information

  • NEWS
    • Press Releases
    • Media Relations

  • ABOUT COVANCE
    • Company Overview
    • Global Locations
    • Corporate Responsibility
    • Business Integrity Program
    • Animal Welfare
    • Covance.Asia

  • RESOURCE CENTER
    • Blog
   
 
 
   
Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its discovery, nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.
Biosimilars Development
Address Key Considerations
and Unique Challenges

Article and webinar available
  Xcellerate®
Shorten the Road to Successful Clinical Trials
Learn how
6–10 March 2013
International Conference on Alzheimer's and Parkinson's Disease
5–9 March 2013
American Society for Clinical Pharmacology & Therapeutics
31 January – 1 February 2013
Immunogenicity and Immunotoxicity
17 January 2013
Covance and the Royal Liverpool and Broadgreen University Hospitals NHS Trust Establish Exclusive Agreement to Collaborate on Early Clinical Research
7 January 2013
Covance To Present At The 31st Annual J. P. Morgan Healthcare Conference
3 January 2013
Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2012 Financial Results Conference Call
News: Read More   |   Events: Read More
Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2013 Covance Inc. All rights reserved.